六问腹泻合理用药

2017-04-12 徐红冰 上海市第一人民医院临床药学科 上海药讯

腹泻是一个常见的症状,主要是由病毒、细菌、食物毒素、肠过敏、全身性疾病等或化学性毒物等原因造成的胃肠分泌、消化、吸收和运动等功能紊乱的结果。据统计,我国每年有数亿人次受到急性腹泻的侵袭。本文就腹泻用药常见问题做一解答。

腹泻是一个常见的症状,主要是由病毒、细菌、食物毒素、肠过敏、全身性疾病等或化学性毒物等原因造成的胃肠分泌、消化、吸收和运动等功能紊乱的结果。据统计,我国每年有数亿人次受到急性腹泻的侵袭。本文就腹泻用药常见问题做一解答。

问题一:腹泻是否都需要使用抗菌药物?

答:腹泻有感染性与非感染性之分,感染性腹泻是由细菌、病毒、真菌、寄生虫等病原体引起,如菌痢、细菌性食物中毒、病毒性肠炎等;抗菌药物可选用黄连素、庆大霉素、氟哌酸、左氧氟沙星等,对肠球菌、肠杆菌、志贺杆菌、螺旋杆菌、霍乱弧菌等有较好的作用。非感染性腹泻一般不需要使用抗菌药物。

世界卫生组织(WHO)提出,90%腹泻不需抗菌药物治疗。

问题二:止泻药分哪几类?

答:止泻药为治疗腹泻的、对症治疗的。主要是通过减少肠蠕动或保护肠道免受刺激而达到止泻效果。止泻药适用于剧烈腹泻或长期慢性腹泻,以防止机体过度脱水、水盐代谢失调、消化或营养障碍。按其药理作用可分为四类:

①改变肠道功能运动功能药,此类药能提高胃肠张力,抑制肠蠕动,制止推进性收缩,代表药物有吗啡、复方樟脑酊、地芬诺酯、洛哌丁胺等。

②肠黏膜保护剂也称吸附剂,其通过表面的吸附作用而吸附肠道气体、细菌、病毒、外毒素,阻止其被吸收或损害肠黏膜。药物有药用炭、白陶土、思密达等。其中代表药物思密达主要成分是双八面体蒙脱石微粒,其对病毒、细菌及其毒素等攻击因子有强大吸附作用,避免使用广谱抗菌药物引起的菌群紊乱。

③收敛保护剂,在肠黏膜上形成保护膜,代表药物如鞣酸蛋白、碱式碳酸铋。

④其他,如考来烯胺在肠内能与胆酸络合,可有效控制腹泻。

问题三:什么叫微生态制剂,在腹泻治疗中起什么作用?常用的有哪些?

答:微生态制剂,通过调整微生态失调,提高宿主健康水平,利用对宿主有益的正常微生物或促进物质制成的制剂。微生态制剂通过增加腹泻患者肠道内有益菌的数量和活力,抑制致病菌的生长,以恢复正常的菌群平衡,达到缓解腹泻症状的效果。但需注意的是其不能与抗生素合用。常用微生态制剂有丽珠肠乐(双歧杆菌)、乳酸菌素(乳酸菌)、妈咪爱(枯草杆菌、屎肠球菌)、培菲康(双歧杆菌、嗜酸乳杆菌、粪肠球菌)、米雅(芽孢酪酸菌)、整肠生(地衣芽孢杆菌)、金双歧(长双歧杆菌、保加利亚乳杆菌、嗜热链球菌)等。

问题四:如何做到合理使用各种腹泻药物?

答:腹泻是人体自我保护的一种体现,借此可排泄掉一部分毒素。原则上讲,止泻药只适用于非感染性腹泻,而感染性腹泻一般不用,尤其是在急性期、炎症及中毒症状(如高烧)较明显、脓血便较多时,应视为止泻剂的绝对禁忌;如急性发作期呕吐、腹泻、脱水情况较严重,应立即静脉补液或口服糖盐粉,并注意酸碱平衡。到了恢复期,病情明显好转大便不带脓血仅是水分较多时,也可短时服用止泻剂。

其次,要注意病因不同,用药有别。如果是肠蠕动增快所致,比如:甲亢、糖尿病和胃肠功能紊乱等,应首选肠蠕动抑制剂。如果是由肠黏膜分泌增加引起的腹泻,如霍乱、细菌性食物中毒等,可以选择收敛剂和吸附剂,通过抑制肠黏膜分泌及吸附有害毒素起到止泻作用。如果是由于黏膜炎症和溃疡导致渗出增加引起的腹泻,可以选择黏膜保护剂,以保护黏膜,清除病原体。因肠道内菌群失调引起的婴幼儿腹泻和抗生素相关性腹泻,应该首选微生态制剂,恢复肠道内微生态平衡。

问题五:对病毒性腹泻应如何防治?

答:病毒性腹泻是导致婴幼儿死亡的主要原因之一。包括轮状病毒、杯状病毒、星状病毒和肠腺病毒等。目前对这类腹泻还没有特效药,主要是预防为主。口服轮状病毒疫苗对儿童具有良好的免疫效果和安全性。

问题六:腹泻与甲亢有关吗?

答:临床上,反复腹泻类似急性胃肠炎,时常也是甲亢的症状之一。甲亢引起的腹泻症状表现为顽固性腹泻或大便次数增加,大便呈稀糊状或水样便。这种腹泻很少伴有腹痛,肠镜检查发现不了异常。如果反复、长期腹泻,除了要考虑消化道方面的病变,还要考虑到是不是甲亢等疾病引起的。如果对自己是否患有甲亢存有怀疑,不妨抽血检测一下甲状腺功能。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-18 186****0580(小山羊)

    学习了谢谢了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-18 cuiyejia

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-17 wen2009

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-17 flysky120

    学习一下知识,谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-16 JusTice

    跨科学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-15 cuiyejia

    谢谢分享,学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=188493, encodeId=779818849367, content=学习了谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Tue Apr 18 09:27:22 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188388, encodeId=aa28188388b3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Tue Apr 18 07:24:07 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188225, encodeId=de4b188225a5, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Mon Apr 17 11:41:49 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188168, encodeId=b557188168d1, content=学习一下知识,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Apr 17 09:11:05 CST 2017, time=2017-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187890, encodeId=2a7718e8902e, content=跨科学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3oV03UEKmQpd02wCrPlHfNEK02oTwiclkkDTVny3EebtBAPEw88tgwBcjlYAReAqsYtncWzltfcN/0, createdBy=311c1958416, createdName=JusTice, createdTime=Sun Apr 16 11:17:34 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187626, encodeId=c9cb18e626ca, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Sat Apr 15 09:16:50 CST 2017, time=2017-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337311, encodeId=2d3d133e311f7, content=<a href='/topic/show?id=a2c038861a1' target=_blank style='color:#2F92EE;'>#合理用药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38861, encryptionId=a2c038861a1, topicName=合理用药)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Fri Apr 14 02:29:00 CST 2017, time=2017-04-14, status=1, ipAttribution=)]

相关资讯

收藏:这37条医学常识,医生可能都不知道!

普通的病毒性感冒并不能被治疗,也不需要治疗。

婴幼儿腹泻,啥该吃啥不该吃?

每到天气转凉时,医院儿科的候诊室里挤满了因上吐下泻而精神萎靡的婴幼儿。秋、冬季婴幼儿腹泻最常见的原因是轮状病毒感染,除此以外,其他病毒/细菌/真菌感染、饮食因素、气候因素、全身性疾病等原因均可引起腹泻[1]。腹泻会引起水分及营养的流失,影响营养的吸收,对婴幼儿的生长发育造成不利影响,所以腹泻治疗的重要性不言而喻。除了药物治疗以外,正确的营养管理也同等重要,能帮助腹泻患儿尽快康复,是治疗方案中不容忽

哈尔滨医科大学数十人感染诺如病毒!揭秘诺如病毒感染!

16日上午,有爆料人称,哈尔滨医科大学发生疑似诺如病毒感染,涉及人员达数十人。据内部人士透露,从13日晚上开始,有部分学生出现呕吐、腹泻等症状,疑似感染诺如病毒的人数陆续增加,16日上午在校内医务处等单位观察治疗。16日下午,新华社记者接到哈医大宣传统战部部长陈英云的电话和回复邮件。邮件称:2016年10月13日22时,哈尔滨医科大学接到部分学生消化系统不适,出现呕吐、发热、腹泻的反映,学校相继护

艾滋病毒和腹泻:原因和关系

【腹泻和艾滋病毒之间的关系是什么?】腹泻是用于描述肠运动的重量,体积和频率的增加的术语,其通常是松散的和水样的。

CLIN CANCER RES:布地奈德对卡巴他赛导致的腹泻无效

转移性去势抵抗性前列腺癌有多种治疗方案,在使用卡巴他赛治疗的实验报道中腹泻发生率为47%。有6%的患者出现3-4级腹泻,需要入院进行治疗。

腹泻竟然有可能是……甲亢

王女士今年36岁,说来也奇怪,近两年一直拉肚子,有时候一天得去厕所三五次。刚开始时她以为是“肠炎”,想着在药房买点“泻立停”吃就好了,但一直没见好。“肠胃”不好的王女士,饭量却在逐渐增大,体重反而轻了10斤。在爱人和儿子的劝说下,她决定去医院看看。到医院系统检查才发现,腹泻的罪魁祸首竟然不是所谓的肠炎,而是“甲状腺功能亢进症”。腹泻也可能是甲亢的症状甲状腺功能亢进症就是俗话说的“甲亢”,对于大